Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Montreal, Canada
Countries of investment
  • Canada
Investment stages
  • Seed
  • Series A
Industries
  • Life Sciences
  • Health Tech
  • Biotechnology
  • MedTech
About
AmorChem is a leading early stage venture fund creating innovative biotech companies from academic research, with a focus on groundbreaking therapies.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

AmorChem is a leading early stage venture capital fund dedicated to creating a new generation of biotechnology companies, from university research to innovative biotech startups. They leverage academic entrepreneurship to generate sustainable health and wealth and focus on translational research to accelerate therapeutic drug discovery and development across a broad spectrum of disease areas.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Focused on technology investments across North America and Europe, the manager has actively participated in 50+ deals. Specializes in late-stage companies with a preference for scalable business models. Known for driving successful exits, achieving a robust portfolio return through strategic partnerships. Backed by a top-tier network, the approach emphasizes a hands-on operational support model to enhance growth trajectories.

Amorchem Contacts Information

Primary contact

Secondary contact

Team

Inès Holzbaur

John Clement

Maxime Ranger

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp